GPR87: A Drug Target / Disease Biomarker (G53836)

Target Name: GPR87

NCBI ID: G53836

GPR87

GPR87: A Drug Target / Disease Biomarker

GPR87 is a G protein-coupled receptor located on the surface of many different types of cells in the body. It is involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation. As a drug target, GPR87 is of interest to researchers because it is a potential target for a variety of different drugs, including those used to treat everything from depression and anxiety to heart disease and cancer.

GPR87 is a member of the G protein-coupled receptor family, which is a large superfamily of transmembrane proteins that are involved in a wide range of cellular processes. The G protein-coupled receptor family includes over 700 different genes, and it is estimated to be responsible for around 50% of all drug responses. This is because these proteins are involved in the signaling pathway that connects the cell membrane to the inside of the cell, and they are the targets of many different drugs.

GPR87 is a G protein-coupled receptor that is located on the surface of many different types of cells, including neurons, muscle cells, and epithelial cells. It is involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation.

GPR87 is involved in sensory perception. For example, it is involved in the sense of touch, and it is thought to play a role in the perception of pain and pressure. It is also involved in the sense of taste, and it is thought to contribute to the sensation of sweetness and sourness.

GPR87 is also involved in neurotransmitter signaling. For example, it is involved in the signaling of dopamine, a neurotransmitter that is involved in a wide range of brain functions, including mood, motivation, and movement. It is also involved in the signaling of serotonin, another neurotransmitter that is involved in mood and anxiety.

GPR87 is also involved in hormone regulation. For example, it is thought to play a role in the regulation of insulin sensitivity, a process that is important for the development and progression of type 2 diabetes. It is also involved in the regulation of sexual function, and it is thought to contribute to the effects of certain hormones on the body.

As a drug target, GPR87 is of interest to researchers because it is a potential target for a variety of different drugs, including those used to treat everything from depression and anxiety to heart disease and cancer. For example, GPR87 is thought to be a potential target for a drug called PZDV, which is being developed as a treatment for depression. Studies have shown that PZDV is able to selectively bind to GPR87 and enhance the effects of a drug called escitalopram, an antidepressant that is currently being used to treat depression.

In addition to its potential as a drug target, GPR87 is also of interest to researchers because it is a relatively small protein that is easy to study. This makes it a good candidate for drug screening experiments, where researchers can use a variety of different techniques to identify small molecules that are able to interact with GPR87 and enhance its effects.

Overall, GPR87 is a drug target that is of interest to researchers because of its involvement in a wide range of physiological processes and its potential as a target for a variety of different drugs. As more research is done on GPR87, it is likely to become a more well-understood target and a valuable tool for the development of new treatments for a wide range of diseases.

Protein Name: G Protein-coupled Receptor 87

Functions: Receptor for lysophosphatidic acid (LPA). Necessary for p53/TP53-dependent survival in response to DNA damage

The "GPR87 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR87 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets